CHINA SXT PHARMACEUTICALS-A
SXTCNASDAQTrading Snapshot
- Day Range
- β
- 52-Week Range
- $2.52 β $8,376,000.00
- Volume (shares)
- β
- Avg Volume (shares)
- β
- Shares Outstanding
- 5,339
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- $1M
- Last Q Revenue
- $1M
- P/E Ratio
- -0.0
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-1,059.25
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +0.0%
CHINA SXT PHARMACEUTICALS-A
SXTCAbout CHINA SXT PHARMACEUTICALS-A
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
News unavailable.